Skip to Main Content

Paper Details

DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemia.
Blood Adv
0
2023
DHODH, DNA, Patients, RNA, T, T lymphoblasts, T-ALL, T-cell, T-cell acute lymphoblastic leukemia, dihydroorotate, dihydroorotate dehydrogenase, human, leukemia, leukemia cells, mice, normal T cells, normal hematopoietic cells, nucleotide, pyrimidine, pyrimidine nucleotide
Author NameAffiliation
Gabriela AlexeDana-Farber Cancer Institute
Gabriela AlexeHarvard Medical School
Gabriela AlexeBroad Institute of MIT and Harvard
Gabriela AlexeDana-Farber Cancer Institute
Gabriela AlexeBroad Institute of MIT and Harvard
Gabriela AlexeHarvard Medical School
Yana PikmanDana-Farber Cancer Institute
Yana PikmanBoston Children's Hospital
Kimberly StegmaierDana-Farber Cancer Institute
Kimberly StegmaierBoston Children's Hospital
Kimberly StegmaierBroad Institute of MIT and Harvard
Kimberly StegmaierDana-Farber Cancer Institute
Kimberly StegmaierBoston Children's Hospital
Kimberly StegmaierBroad Institute of MIT and Harvard
  • 1 - 14

Datasets

Release 1.2